Logo

CCCXW

Churchill Capital Corp X Warrants

CCCXW

Churchill Capital Corp X Warrants • NASDAQ
$6.12 ▲ 1.49% (+0.09)
Market Cap $315.89 M
52w High $6.49
52w Low $6.10
Dividend Yield 0%
P/E 0
Volume 56.06K
Outstanding Shares 51.62M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $1.235M ▲ $-33.385M ▼ 0% $-0.64 ▼ $0 ▲
Q2-2025 $0 $185.232K ▲ $1.973M ▲ 0% $0 $-185.232K ▼
Q1-2025 $0 $18.2K ▲ $-18.2K ▼ 0% $0 $-18.2K ▼
Q2-2024 $0 $7.23K ▼ $-7.23K ▲ 0% $0 $-7.23K ▲
Q1-2024 $0 $44.611K $-44.611K 0% $0 $-44.611K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $420.688M ▲ $421.269M ▲ $39.697M ▲ $-37.98M ▼
Q2-2025 $1.232M $418.06M $3.103M $414.957M

Five-Year Company Overview

Income Statement

Income Statement As of now, Churchill Capital Corp X is essentially an empty shell, so its income statement does not tell you much about an operating business. It has no real revenue, no gross profit, and no meaningful operating activity. The future income picture is really about Infleqtion after the merger closes. Infleqtion already sells quantum sensing products and has a growing customer list, but it is still in an early, investment-heavy phase where long-term growth matters more than short-term profits. Expect the combined company’s income statement to be driven by research spending and business development for quite some time rather than steady earnings.

Balance Sheet

Balance Sheet The current balance sheet of Churchill Capital Corp X is typical of a SPAC: mostly cash held in trust and very little in the way of traditional operating assets or liabilities. There is no detailed view yet of the post-merger balance sheet, but the plan is for Infleqtion to receive a substantial capital injection to fund its roadmap. That should provide a financial cushion, but a deep-tech company like this is likely to need ongoing investment. Over time, equity raises, warrant exercises, or other financing could change the capital structure and dilute existing holders, which is common in high-growth, R&D-intensive businesses.

Cash Flow

Cash Flow Today, Churchill Capital Corp X generates no operating cash flow because it has no operating business; it mainly incurs administrative costs. After the merger, cash flow will depend on Infleqtion’s ability to grow sales of quantum sensing, computing, and software solutions while controlling its spending. For several years, it is reasonable to expect cash to flow out of the business as it funds research, product development, and customer pilots. The key question will be whether revenue and contracted projects ramp fast enough to gradually narrow this gap and extend the company’s cash runway before more capital is needed.

Competitive Edge

Competitive Edge Infleqtion enters the market with a differentiated technology approach in neutral atom quantum systems, which offers potential advantages in scalability and operating costs compared with some rival platforms. It has already built credible partnerships with major governments, defense agencies, and large technology companies, which provides validation and helps open doors to sensitive, high-value use cases. At the same time, the broader quantum field is crowded, with well-funded competitors and big tech firms pursuing alternative technologies. The company’s competitive position will hinge on whether it can translate its technical lead and relationships into repeatable commercial deployments before rivals close the gap or standards tilt toward other architectures.

Innovation and R&D

Innovation and R&D The heart of the story is innovation. Infleqtion’s platform is built on many years of research in neutral atom quantum technology and supported by a large patent portfolio that helps protect its ideas. It is not only building quantum computers but also commercial quantum sensing products and its own software stack, which broadens its opportunity set. The company has set an ambitious roadmap toward more advanced, fault-tolerant systems by the end of the decade, with clear technical milestones along the way. That path is promising but uncertain: success depends on sustained R&D execution, recruitment and retention of specialized talent, and continued support from partners and government programs.

Summary

CCCXW represents a warrant tied to a SPAC that currently has almost no operating business of its own; the real underlying story is the planned merger with Infleqtion, a quantum technology company. Traditional financial statements for Churchill Capital Corp X are not very informative at this stage, since they reflect a cash shell rather than a functioning enterprise. The attraction here is the potential of Infleqtion’s neutral atom quantum platform, existing commercial products, and strong institutional relationships, balanced against the usual risks of early-stage, deep-tech ventures: high spending needs, uncertain timelines, intense competition, and reliance on successful execution of a long-term roadmap. Anyone following CCCXW is essentially tracking whether the merger closes as expected and how well Infleqtion delivers on its technical milestones, customer adoption, and capital management in the years that follow.